Rainmed Medical Limited (HKG:2297)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2260
+0.0030 (1.35%)
Jun 1, 2026, 4:08 PM HKT
Market Cap312.50M +46.2%
Revenue (ttm)21.34M -51.8%
Net Income-85.78M
EPS-0.07
Shares Out 1.40B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume279,000
Open0.2260
Previous Close0.2230
Day's Range0.2250 - 0.2260
52-Week Range0.1710 - 0.5300
Beta0.60
Analystsn/a
Price Targetn/a
Earnings DateJun 4, 2026

About Rainmed Medical

Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of ... [Read more]

Sector Healthcare
Founded 2014
Employees 214
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2297
Full Company Profile

Financial Performance

In 2025, Rainmed Medical's revenue was 19.18 million, a decrease of -51.85% compared to the previous year's 39.82 million. Losses were -77.08 million, -32.08% less than in 2024.

Financial numbers in CNY Financial Statements